Jun 10, 2026
403:397
For every 397 shares held, investors received 403. The price per share adjusted from $13.00 to $12.81.
The split itself did not change the total investment value.
Annexin Pharmaceuticals AB (STO:ANNX) operates in the Pharmaceuticals: major industry.
Annexin Pharmaceuticals AB company overviewAnnexin Pharmaceuticals AB's most recent stock split was on June 10, 2026. It was a 403-for-397 forward split, so shareholders received 403 shares for every 397 they held.
Annexin Pharmaceuticals AB (STO:ANNX) has split its stock 6 times: a 418-for-277 split on February 3, 2020, a 1129-for-684 split on November 27, 2023, a 683-for-639 split on May 8, 2024, a 890-for-869 split on March 4, 2025, a 1-for-100 reverse split on May 28, 2025, and a 403-for-397 split on June 10, 2026.
Annexin Pharmaceuticals AB has split its stock 6 times. This history records 6 splits between February 3, 2020 and June 10, 2026.
A stock split divides each share into more shares and lowers the price per share by the same factor, so the total value of a holding does not change. In Annexin Pharmaceuticals AB's 403-for-397 split on June 10, 2026, every 397 shares became 403 shares.
Annexin Pharmaceuticals AB has not announced a new split in our records. Its most recent split was on June 10, 2026, less than a year ago. Companies announce splits in advance, and any new STO:ANNX split will appear on this page.
Already premium?